Antibacterial and Antibiofilm Potential of Bacterial Cellulose Hydrogel Containing Vancomycin against Multidrug-Resistant Staphylococcus aureus and Staphylococcus epidermidis

Author:

Correia Ana Alice Venancio1ORCID,de Almeida Campos Luís André1,de Queiroz Macêdo Hanne Lazla Rafael1ORCID,de Lacerda Coriolano Davi1ORCID,Agreles Maria Anndressa Alves1,Xavier Danilo Elias2ORCID,de Siqueira Ferraz-Carvalho Rafaela3,de Andrade Aguiar José Lamartine3,Cavalcanti Isabella Macário Ferro14ORCID

Affiliation:

1. Keizo Asami Institute (iLIKA), Federal University of Pernambuco (UFPE), Recife 50670-901, Brazil

2. Department of Microbiology, Aggeu Magalhães Institute, FIOCRUZ-PE, Recife 50740-465, Brazil

3. Department of Surgery, Federal University of Pernambuco (UFPE), Recife 50670-901, Brazil

4. Laboratory of Microbiology and Immunology, Academic Center of Vitória (CAV), Federal University of Pernambuco (UFPE), Vitória de Santo Antão 55608-680, Brazil

Abstract

The present study aimed to evaluate the in vitro antibacterial and antibiofilm activity of bacterial cellulose hydrogel produced by Zoogloea sp. (HYDROGEL) containing vancomycin (VAN) against bacterial strains that cause wound infections, such as multidrug-resistant (MDR) Staphylococcus aureus and Staphylococcus epidermidis. Initially, HYDROGEL was obtained from sugar cane molasses, and scanning electron microscopy (SEM) was performed to determine morphological characteristics. Then, VAN was incorporated into HYDROGEL (VAN-HYDROGEL). The antibacterial activity of VAN, HYDROGEL, and VAN-HYDROGEL was assessed using the broth microdilution method to determine the minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) against methicillin-sensitive S. aureus (MSSA) ATCC 25923, methicillin-resistant S. aureus (MRSA) ATCC 33591, S. epidermidis INCQS 00016 (ATCC 12228), five clinical isolates of MRSA, and nine clinical isolates of methicillin-resistant S. epidermidis, following the Clinical and Laboratory Standards Institute (CLSI) guidelines. Additionally, the antibacterial activity of VAN, HYDROGEL, and VAN-HYDROGEL was studied using the time-kill assay. Subsequently, the antibiofilm activity of VAN, HYDROGEL, and VAN-HYDROGEL was evaluated using crystal violet and Congo red methods, as well as SEM analysis. VAN and VAN-HYDROGEL showed bacteriostatic and bactericidal activity against MRSA and methicillin-resistant S. epidermidis strains. HYDROGEL did not show any antibacterial activity. Analysis of the time-kill assay indicated that HYDROGEL maintained the antibacterial efficacy of VAN, highlighting its efficiency as a promising carrier. Regarding antibiofilm activity, VAN and HYDROGEL inhibited biofilm formation but did not demonstrate biofilm eradication activity against methicillin-resistant S. aureus and S. epidermidis strains. However, it was observed that the biofilm eradication potential of VAN was enhanced after incorporation into HYDROGEL, a result also proven through images obtained by SEM. From the methods carried out in this study, it was possible to observe that HYDROGEL preserved the antibacterial activity of vancomycin, aside from exhibiting antibiofilm activity and enhancing the antibiofilm effect of VAN. In conclusion, this study demonstrated the potential of HYDROGEL as a candidate and/or vehicle for antibiotics against MDR bacteria that cause wound infections.

Publisher

MDPI AG

Reference68 articles.

1. Bioengineering Considerations in the Prevention of Medical Device-Related Pressure Ulcers;Bader;Clin. Biomech.,2019

2. Topical Application of Bacteriophages for Treatment of Wound Infections;Chang;Transl. Res.,2020

3. Hospital Triage and Skin Disease: Hospital Outcomes Are Differentially Associated with Cutaneous Morphology;Pettit;Int. J. Dermatol.,2023

4. (2024, May 01). Novo Relatório Pede Ação Urgente Para Evitar Crise De Resistência Antimicrobiana—OPAS/OMS|Organização Pan-Americana da Saúde. Available online: https://www.paho.org/pt/noticias/29-4-2019-novo-relatorio-pede-acao-urgente-para-evitar-crise-resistencia-antimicrobiana-0.

5. Recent Innovations in Bacterial Infection Detection and Treatment;Deusenbery;ACS Infect. Dis.,2021

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3